Prognostic Factors in Lung Cancer Treatment
Author Information
Author(s): Ataman Ö U, Bentzen S M, Saunders M I, Dische S
Primary Institution: Gray Cancer Institute, Mount Vernon Hospital Northwood, Middlesex, UK
Hypothesis
The study aims to identify failure-specific prognostic factors in non-small-cell lung cancer.
Conclusion
The study found that certain factors, such as treatment type and age, influence the time until failure in lung cancer patients.
Supporting Evidence
- Randomization to CHART was associated with a prolonged interval to failure.
- Increasing age was linked to a longer time until failure.
- Female sex showed a trend towards a longer interval to failure.
- Advanced clinical stage was associated with a decreased interval to failure.
- Patients with advanced stage had a higher risk of distant failure.
Takeaway
This study looked at how different factors affect the success of lung cancer treatments, helping doctors understand which patients might need more help.
Methodology
The study analyzed clinical outcomes using a competing risk analysis with a log-logistic hazard function.
Participant Demographics
The study included 549 patients with non-small-cell lung cancer.
Statistical Information
P-Value
p=0.005 for CHART treatment, p=0.036 for age, p=0.09 for female sex, p=0.004 for advanced stage, p=0.009 for distant failure risk.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website